SCHEMBL5779376

SCHEMBL5779376

CSc1nccc(-c2sc(N)nc2-c2ccccc2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
MAPT P10636 5/20 0.55
CYP1A2 P05177 2/20 0.55
CYP2D6 P10635 2/20 0.55
CYP2C19 P33261 2/20 0.55
MAPK1 P28482 4/20 0.53
KDM4E B2RXH2 3/20 0.53
NPSR1 Q6W5P4 3/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MAPK13 O15264 1/20 0.52
MAPK12 P53778 1/20 0.52
MAPK11 Q15759 1/20 0.52
MAPK14 Q16539 1/20 0.52
CYP3A4 P08684 1/20 0.50
GAA P10253 1/20 0.50
CYP2C9 P11712 1/20 0.50
CSNK1E P49674 1/20 0.46
LMNA P02545 3/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6840123 0.90 ALDH1A1 (0.55) ALDH1A1MAPTCYP1A2CYP2D6CYP2C19
SCHEMBL5819182 0.87 TGFBR1 (0.57) ALDH1A1MAPTMAPK1KDM4ENPSR1
SCHEMBL5818242 0.87 MAPK14 (0.47) ALDH1A1MAPTCYP1A2CYP2D6CYP2C19
SCHEMBL5812178 0.86 TGFBR1 (0.61) ALDH1A1MAPTCYP1A2CYP2D6CYP2C19
SCHEMBL5819641 0.86 TGFBR1 (0.45) ALDH1A1MAPTCYP1A2CYP2D6CYP2C19
SCHEMBL5815379 0.85 MYC (0.47) ALDH1A1MAPTCYP1A2CYP2D6CYP2C19
SCHEMBL5817815 0.83 MAPK14 (0.44) MAPK1KDM4ENPSR1L3MBTL1MAPK13
SCHEMBL5815955 0.83 TGFBR1 (0.56) MAPK1KDM4ENPSR1L3MBTL1MAPK13
SCHEMBL1641146 0.81 MYC (0.52) ALDH1A1MAPTMAPK1KDM4ENPSR1
SCHEMBL24760755 0.80 ALDH1A1 (0.59) ALDH1A1MAPTCYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105517-B2 Thiazolyl substituted aminopyrimidines as plant protection agents SYNGENTA CROP PROTECTION, INC. (US) 2006-09-12 US disclosed
EP-1434776-B1 THIAZOLYL SUBSTITUTED AMINOPYRIMIDINES AS PLANT PROTECTION AGENTS SYNGENTA PARTICIPATIONS AG (CH) 2006-06-28 EP disclosed
US-20050038059-A1 Thiazolyl substituted aminopyrimidines as plant protection agents SYNGENTA CROP PROTECTION, INC. 2005-02-17 US disclosed
EP-1434776-A1 THIAZOLYL SUBSTITUTED AMINOPYRIMIDINES AS PLANT PROTECTION AGENTS Syngenta Participations AG (CH) 2004-07-07 EP disclosed
WO-2003029249-A1 THIAZOLYL SUBSTITUTED AMINOPYRIMIDINES AS PLANT PROTECTION AGENTS SYNGENTA PARTICIPATIONS AG (CH) 2003-04-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038059-A1 Thiazolyl substituted aminopyrimidines as plant protection agents RARS2, CYP4X1, QDPR ALDH1A1 243/4885MAPT 1623/4885CYP1A2 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.